Need Help? Call 1­-866-­796-­7386
« back to stock screener

  HALO stock: Halozyme Therapeutics, Inc.

Current Rating
Strong Buy

Previous Rating

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$18.24
Market Cap
2.68B
Sector
Health Care
Div. Growth
-
P/E
42.4
P/B
13.25
P/S
8.72
Dividend %
-
P/CF
26.8
P/FCF
23.3
Op. Cash Flow
134.1K
FCF
0.8
Op. Margin
25.60%
Net Margin
19.90%
ROE
89.80%
ROI
24.20%
ROA
17.40%
EPS Growth
150.70%
Current Ratio
3.9
Debt/Equity
60.00%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Milestone Scientific Inc. (MLSS) $0.85 - - 25.9M Strong Buy
Heat Biologics Inc (HTBX) $1.99 - - 6.3M Strong Buy
Halyard Health Inc (HYH) $53.69 - - 2.16B Strong Buy
Misonix, Inc. (MSON) $12.60 - - 103.4M Strong Buy
Envision Healthcare Corp (EVHC) $42.92 - - 4.61B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More